NewsRoom Articles - Page 169 of 231

WednesdayJul 14, 2021 10:00 am

Researchers May Have Found Way to Retain Bladder After Bladder Cancer Diagnosis

Cancer metastasis is every patient and doctor’s nightmare when it comes to treating this deadly disease. Chemotherapy is usually the primary treatment option, with doctors following up with surgeries to remove any tumors. However, patients suffering from muscle-invasive bladder cancer have to make a life-altering decision to either undergo chemotherapy and have their bladder removed to reduce chances of the cancer recurring or take their chances with the cancer metastasizing and leave their bladder intact while undergoing chemotherapy. Cystectomy, which refers to the surgical removal of the bladder, is the standard treatment plan for individuals who suffer from muscle-invasive bladder…

TuesdayJul 13, 2021 10:13 am

Study Explores Debilitating Childhood Brain Cancer Treatment Options

A recent study by the St. Jude Children’s Research Hospital and the School of Medicine at the Washington University in St. Louis proposes that young patients with an average risk medulloblastoma can, after a six-week radiation treatment regimen, undergo a radiation boost to a smaller area of the brain. Medulloblastoma is a pediatric brain cancer that usually affects the spine and/or brain and can spread through a patient’s spinal fluid. The standard of care for this type of cancer includes radiation therapy to the whole spine and brain, after which an extra dose of radiation to the back of the…

MondayJul 12, 2021 12:50 pm

Cognitive Problems in Childhood Could Trigger Mental Health Issues Later in Life

New research conducted by a group of scientists from Finland and the UK, led by a team from University of Birmingham, has found that children who experience cognitive difficulties such as a lack of inhibition, poor memory or low attention may suffer from mental health problems as young adults or teenagers. On a global scale, mental disorders affect about 10% of adolescents and children, with researchers finding that 75% of the disorders diagnosed in adulthood usually begin during adolescence or childhood. For instance, disorders such as psychosis, depression and bipolar disorder often emerge during adolescence and continue into adulthood. The…

MondayJul 12, 2021 12:42 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Marks Major Milestone for its Rapid Point-Of-Care Diagnostic Business Strategy

XPhyto began delivery of approximately 1,000 Covid-ID Lab test kits in Berlin This marks a significant achievement commercially, as well as for the company’s point-of-care diagnostic business strategy The lab tests are designed to offer reliable Covid-19 test results in under 25 minutes XPhyto plans to capitalize on the rapid test market, projected to reach $39.1 billion by 2023 For the week starting June 27, 2021, XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) began delivery of approximately 1,000 Covid-ID Lab test kits to 10 different test centers in Berlin, Germany. This move is a major commercial achievement for the…

FridayJul 09, 2021 2:00 pm

MSK Oncologists Share Approaches to Raise Survival Rates Among Soft Tissue Sarcoma Sufferers

Research has shown that nearly 50% of patients suffering from soft tissue sarcoma develop lung tumors. Presently, pulmonary metastasectomy, which is the surgical removal of lung tumors, is the primary treatment option for the disease as effective systemic treatments for metastatic soft tissue sarcoma are scarce. Despite this, guidelines for performing a pulmonary metastasectomy for soft tissue sarcoma don’t exist. and decisions to carry out the surgery are usually made on a person-to-person basis. During the 96th annual American Association for Thoracic Surgery meeting, scientists from the Memorial Sloan Kettering Cancer Center gave a presentation on prognostic factors and survival…

ThursdayJul 08, 2021 1:04 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Similar Strategy as Leading Cannabis-Derived Compound Pharmaceutical Company

Jazz Pharmaceuticals’ acquisition of GW Pharma for $7.2 billion in February 2021 shows the massive potential of the drug development industry from naturally-derived compounds Tryp Therapeutics is following in the footsteps of GW with its innovative drug pipeline and the development of psilocybin-based compounds for the treatment of diseases with high unmet medical needs It is one of only a handful of companies moving into Phase 2a clinical trials with a psychedelic compound, and seeks to duplicate the success of GW As of 2020, the global biotech sector was valued at $753 billion. It is further projected to grow at…

ThursdayJul 08, 2021 10:00 am

Telehealth and Its Usefulness Beyond the Coronavirus Pandemic

The coronavirus pandemic forced many physicians to switch from in-person visits to telehealth in a bid to keep their patients safe and also prevent the virus from spreading. While this may have been a temporary solution for some, many herald it as the future, with one industry expert urging optometrists to continue utilizing the technology for their practices even as in-person visits resume. Christopher Wolfe recently gave a presentation at Vision Expo East in which he explained how at the onset of the coronavirus pandemic, instructions were given to not offer emergent or urgent care via telemedicine, revealing that in…

WednesdayJul 07, 2021 10:27 am

Predictive Oncology Inc. (NASDAQ: POAI) Companies Build New Labs, Expand Services for New Drug Discoveries

Two of Predictive Oncology’s four subsidiaries are constructing new Good Manufacturing Practices laboratories to offer additional services to customers With its new GMP lab, Soluble Biotech will provide customers formulations that can go directly to clinical trials, as well as manufacture proprietary media used in its chromatography kits TumorGenesis will use its GMP lab to produce its proprietary media that tricks tumor cells into growing outside the body the same as inside the body in addition to producing proteins and other biological products used in diagnosing, treating, and modifying tumor cells On the heels of raising $21.34 million and three…

WednesdayJul 07, 2021 9:45 am

New Blood Test Could Speed Up Diagnosis of Brain Cancer

A study conducted at the University of Strathclyde, in collaboration with clinicians from the Walton NHS Foundation Trust, the University of Liverpool and the Western General Hospital, has helped design a blood test that speeds up brain cancer diagnosis. This patented technology uses infrared light to produce a blood sample’s biosignature then utilizes artificial intelligence to check for any signs of cancer. The technology, which was reported in the “Nature Communications” journal, is being commercialized by ClinSpec Diagnostics Limited. The study was led by ClinSpec Diagnostics chief scientific officer Dr. Matthew J. Baker, who also happens to be a reader…

TuesdayJul 06, 2021 1:05 pm

The Coronavirus Pandemic Has Adversely Affected Genitourinary Cancer Patients

The findings of an initial virtual survey that was presented at the 2021 Genitourinary Cancers Symposium demonstrate that the coronavirus pandemic had a negative influence on patients who suffer from genitourinary malignancies. Genitourinary cancers are mainly found in the male reproductive system and the urinary system. These cancers include adrenal cancer, testicular cancer, urethral cancer, bladder cancer, kidney cancer, prostate cancer and cancers of the penis. The preliminary survey highlights that as a result of the pandemic, almost 12% of study participants missed at least one dose of a prescribed medication, 12% avoided making the trip to a pharmacy to…